Allergan developed and approved a new muscle enhancer

June 24th Allergan, the world's leading medical supplies giant, announced that its CoolTone device had been approved by the FDA to improve the abdominal muscles, strengthen the abs and build a tighter abdomen. CoolTone can also be used for muscle strengthening in the hips and thighs.CoolTone is the latest member of Allergan's body contour portfolio to penetrate magnetic stimulation (MMS) technology into the muscle layer and induce the muscle to contract involuntarily, strengthening the muscle fibers as the muscles contract. Whether in the abdomen, buttocks or thighs, CoolTone strengthens the muscles that hold the treatment area and creates a clearer and more fit look.It is important to note that CoolTone cannot be applied to the head or heart area, nor can the active drug be applied to the metal panel on which the device touches the skin. Patients with haemorrhagic diseases, epilepsy, and menstrual women use CoolTone with caution, and the most common adverse reactions caused by the device include temporary muscle spasms, temporary joint or tendon pain, local erythema, and redness of the skin." as a global leader in medical beauty, Allergan focuses on developing non-surgical beauty solutions that are continuously innovative and safe and effective. Brad Hauser, Vice President of Body Contour Research and Development at Allergan, said, "We do this by developing differentiated technologies to meet the medical needs of patients. In , Allerga has been working with Marina Plastic Surgery, a plastic surgery clinic in Los Angeles, california. Grant Stevens, the clinic's founder, said of the new product's approval: "By working with Allergan, we can offer our patients new medical solutions for body contours. CoolSculpting is our most commonly used non-surgical lipid reduction technique in clinical practice, and now we can recommend CoolTone's muscle training to enhance the tightness of the abdomen, hips and thighs. For , Allergan has started receiving pre-orders from CoolTone and plans to begin shipping in the early fourth quarter of 2019.
About AllerganAllergan (NYSE:AGN) is a global pharmaceutical leader founded in 1948 by pharmacist Gavin S. Herbert and headquartered in Dublin, Ireland. Allergan focuses on four areas: medical beauty, ophthalmology, central nervous system diseases and gastroenterology, with operations in approximately 100 countries and more than 17,000 employees.
(arterial
)